75 related articles for article (PubMed ID: 15523142)
1. Bisphosphonate therapy in polyostotic fibrous dysplasia.
Kumar S
Indian Pediatr; 2004 Oct; 41(10):1069-70. PubMed ID: 15523142
[No Abstract] [Full Text] [Related]
2. Oral bisphosphonates in polyostotic fibrous dysplasia.
Khadilkar VV; Khadilkar AV; Maskati GB
Indian Pediatr; 2003 Sep; 40(9):894-6. PubMed ID: 14530553
[TBL] [Abstract][Full Text] [Related]
3. Oral alendronate treatment for polyostotic fibrous dysplasia: a case report.
Kitagawa Y; Tamai K; Ito H
J Orthop Sci; 2004; 9(5):521-5. PubMed ID: 15449129
[TBL] [Abstract][Full Text] [Related]
4. Alendronate therapy in polyostotic fibrous dysplasia presenting with pathologic fracture.
Jayaraman M; Karikumar K; Verma A; Modi KD
Am J Orthop (Belle Mead NJ); 2011 Mar; 40(3):E48-50. PubMed ID: 21720608
[TBL] [Abstract][Full Text] [Related]
5. Bisphosphonate therapy for fibrous dysplasia.
DiMeglio LA
Pediatr Endocrinol Rev; 2007 Aug; 4 Suppl 4():440-5. PubMed ID: 17982393
[TBL] [Abstract][Full Text] [Related]
6. Fibrous dysplasia of the craniofacial bones.
Lai WS; Lee JC
J Am Osteopath Assoc; 2013 Aug; 113(8):641. PubMed ID: 23918916
[No Abstract] [Full Text] [Related]
7. Oral alendronate in osteogenesis imperfecta.
Unal E; Abaci A; Bober E; Buyukgebiz A
Indian Pediatr; 2005 Nov; 42(11):1158-60. PubMed ID: 16340059
[TBL] [Abstract][Full Text] [Related]
8. Pamidronate for fibrous dysplasia due to McCune Albright Syndrome.
Kochar IP; Kulkarni KP
Indian Pediatr; 2010 Jul; 47(7):633-5. PubMed ID: 20683120
[No Abstract] [Full Text] [Related]
9. Intravenous zoledronic acid 5 mg in the treatment of postmenopausal women with low bone density previously treated with alendronate.
McClung M; Recker R; Miller P; Fiske D; Minkoff J; Kriegman A; Zhou W; Adera M; Davis J
Bone; 2007 Jul; 41(1):122-8. PubMed ID: 17468062
[TBL] [Abstract][Full Text] [Related]
10. [Osteoporotic fracture in menopausal women: alendronate reduces the risk].
Bize R; Lamy O; Peytremann-Bridevaux I
Rev Med Suisse; 2008 Dec; 4(183):2703. PubMed ID: 19157286
[No Abstract] [Full Text] [Related]
11. Lack of scintigraphic response of fibrous dysplasia to bisphosphonate treatment.
Florez H; Peris P; Vidal-Sicart S; Monegal A; Guañabens N
Rheumatology (Oxford); 2016 Oct; 55(10):1735. PubMed ID: 27411478
[No Abstract] [Full Text] [Related]
12. An Oral Bisphosphonate Dilemma.
Whitehouse J
Dent Today; 2015 Jul; 34(7):140-1. PubMed ID: 26285349
[No Abstract] [Full Text] [Related]
13. Response letter to the article: recurrent femur neck fracture and response to bisphosphonates in polyostotic fibrous dysplasia: a novel molecular mechanism.
Namazi H
Indian J Pediatr; 2012 Nov; 79(11):1535; author reply 1535-6. PubMed ID: 22231769
[No Abstract] [Full Text] [Related]
14. Bisphosphonate treatment in polyostotic fibrous dysplasia of the cranium: case report and literature review.
Mansoori LS; Catel CP; Rothman MS
Endocr Pract; 2010; 16(5):851-4. PubMed ID: 20570808
[TBL] [Abstract][Full Text] [Related]
15. Pamidronate treatment of polyostotic fibrous dysplasia: failure to prevent expansion of dysplastic lesions during childhood.
Chan B; Zacharin M
J Pediatr Endocrinol Metab; 2006 Jan; 19(1):75-80. PubMed ID: 16509531
[TBL] [Abstract][Full Text] [Related]
16. Use of high-dose oral bisphosphonate therapy for symptomatic fibrous dysplasia of the skull.
Chao K; Katznelson L
J Neurosurg; 2008 Nov; 109(5):889-92. PubMed ID: 18976079
[TBL] [Abstract][Full Text] [Related]
17. [Patient compliance program aids therapy success].
MMW Fortschr Med; 2009 Mar; 151(11):47. PubMed ID: 19469207
[No Abstract] [Full Text] [Related]
18. Effects of alendronate and hormone replacement therapy, alone and in combination, on saliva, periodontal conditions and gingival crevicular fluid matrix metalloproteinase-8 levels in women with osteoporosis.
Eviö S; Tarkkila L; Sorsa T; Furuholm J; Välimäki MJ; Ylikorkala O; Tiitinen A; Meurman JH
Oral Dis; 2006 Mar; 12(2):187-93. PubMed ID: 16476042
[TBL] [Abstract][Full Text] [Related]
19. [Fibrous dysplasia of bone in a 12-year old girl].
Bieniasz J; Maj A; Noczyńska A
Endokrynol Diabetol Chor Przemiany Materii Wieku Rozw; 2006; 12(1):69-72. PubMed ID: 16704865
[TBL] [Abstract][Full Text] [Related]
20. [Postmenopausal osteoporosis. Bisphosphonates are not all equal].
MMW Fortschr Med; 2009 Mar; 151(11):46-7. PubMed ID: 19469206
[No Abstract] [Full Text] [Related]
[Next] [New Search]
